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Objective: To investigate the protective action of tanshinone IIA (TSN) on myocardial apoptosis induced by 
hydrogen peroxide (H2O2) and its effect on prohibitin (PHB) expression to probe the role of PHB in the oxidation 
stress of myocardial cells.  
Methods: Primary cultured neonate rat myocardial cells were cultured with TSN (1×10-4 mol/L) for 24 hours, and 
then the medium was supplemented with 200 µ mol/L hydrogen peroxide for 2 h to initiate myocardial cell oxidative 
stress injury. PHB in myocardial cells was knocked down by small interfering RNA (siRNA), and the expression 
level of PHB was determined by western blot analysis. Flow cytometry was used to detect the apoptosis rate, 
intracellular calcium ion concentration ([Ca2+]i) and mitochondrial membrane potential (MMP).  
Results: The PHB expression, [Ca2+]i and the apoptotic rate significantly increased, and the MMP significantly 
decreased in the oxidative stress group compared with the control. The PHB expression, apoptosis rate and [Ca2+]i 
decreased, and MMP increased significantly in the TSN group compared with the oxidative stress group. Compared 
with the siRNA negative control group, the PHB expression level in myocardial cells was down-regulated, and the 
apoptosis rate and [Ca2+]i increased, and MMP decreased significantly in the siRNA group.  
Conclusion: TSN can reduce PHB expression in oxidative stress-injured myocardial cells hence protecting the 
myocardial cells. 
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With the wide use of coronary thrombolysis, coronary 
saccular dilatation and coronary artery bypass grafting 
for treatment of ischemic heart diseases, ischemia- 
reperfusion injury (I/RI) is an emergent problem.1 Many 
experimental studies have shown that a large number of 
free radicals are produced in the injured myocardial area, 
and oxidative injury from the free radicals contributes to 
overall myocardial injury. Free radical scavengers have 
been shown to alleviate this injury.2  
Prohibitin (PHB) is located in the inner mitochondrial 
membrane and has been shown to inhibit tumor cell 
proliferation, regulate cell cycles and apoptosis, protect 
mitochondrial function, and prevent ageing.3 Also, PHB 
has anti-inflammatory and anti-apoptosis effects in 
intestinal tissues. Proteomics studies indicate that PHB 
expression increases in myocardial ischemia- 
reperfusion;4 however, there are few reports about its role 
in myocardial injury. 
Danshen ( 丹 参 Radix Salvia miltiorrhiza) is a 
well-known traditional Chinese herb. Tanshinone IIA 
(TSN) is an important active component of Danshen and 
has been widely used for the treatment of coronary heart 
disease.51In the present experiment, the protective action 
of TSN on myocardial cells and its regulative effects on 
PHB expression under conditions of oxidative stress 
were investigated. The function of PHB was studied with 
small interfering RNA (siRNA) interference technique in 
injured myocardial cells induced by hydrogen peroxide 
(H2O2) in vitro to elucidate the molecular mechanism of 
Dansen for the treatment of myocardial ischemic 
diseases. 
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MATERIALS AND METHODS 
Animals 
1–3 day-old SPF Wistar neonatal male rats were 
purchased from the Experimental Animal Center, 
Southern Medical University (Certificate of quality: 
SCXK 粤-20060015). 
Medicines and Reagents 
Trypsin and DMEM culture medium were purchased 
from Gibco (USA); siPORT NeoFX transfection kit was 
purchased from Ambion (USA); fetal calf serum was 
purchased from Hangzhou Sijiqing Biotech Institute; 
TSN was purchased from China Medicines and 
Biological Products Test Institute (Batch No. 110766- 
200417). Prohibitin antibody from the mouse, and goat 
anti-mouse IgG-HRP, prohibitin siRNA and transfection 
reagents were purchased from Santa Cruz Biotechnology 
(USA). ECL chemiluminescence kit and protein 
quantitative determination kit, Fluo-3/AM calcium ion 
fluorescence probe, rhodamine 123 were purchased from 
Biyuntian Biotech Institute, and AnnexinV-FITC cell 
apoptosis detection kit was purchased from Nanjing Key 
Gen Biotech Development Co. 
Grouping 
After primary cultured neonate rat myocardial cells were 
separated and purified, six experimental groups were 
identified: 1) normal control group-myocardial cells 
under normal growth conditions; 2) oxidative stress 
group-myocardial cells growing in the medium 
supplemented with 200 µmol/L H2O2 for 2 h; 3) TSN + 
oxidative stress group-myocardial cells growing in the 
medium supplemented with TSN (1×10-4 mol/L) for 24 h 
before growing under oxidative stress conditions for 2 h; 
4) siRNA group-myocardial cells transfected with 
specific PHB small interfering RNA; 5) siRNA + 
oxidative stress group-after transfection with specific 
PHB small interfering RNA, myocardial cells were 
cultured in the medium supplemented with 200 µmol/L 
H2O2 for 2 h; 6) siRNA negative control group-the 
normal cultured myocardial cells were transfected with 
negative control siRNA. 
Culture of Neonate Rat Myocardial Cells  
Primary myocardial cells from neonatal rats were 
cultured according to the procedure described by 
Goldenberg et al.4 In brief, the hearts were surgically 
taken from 1- to 3-day-old Wistar rats immerged in 75% 
alcohol for 8 s, and the cardiac atrium and epicardial 
connective tissue were removed and the ventricle of 
heart was open and washed for three times with cold 
D-Hanks solution in a culture dish. The muscles of the 
ventricle of the heart were minced into 1–2 mm3 pieces 
by aseptic operation and put into a 5 ml-tube containing 
0.1% trypsin solution at 37℃, for 6 min. After natural 
sedimentation, the first supernatant was dispersed, and 
the precipitate was added to 5 ml of trypsin at 37℃ for 6 
min and gently brown. After natural sedimentation, the 
supernatant was moved into a 15 ml-centrifuge tube 
containing medium with 5% fetal calf serum to end the 
trypsinization, and centrifuged at 1000 rpm for 10 min 
and washed twice. The precipitate was added to fresh 
trypsin to continue digestion. Repeat trypsinization was 
conducted 7–10 times until digestion of all the tissue 
pieces was complete. The final precipitate was used to 
prepare a cell suspension in the presence of medium 
containing 15% fetal calf serum and cultured in a CO2 
incubator for 1 h, and the non-myocardial cells including 
mainly fibroblast and endothelial cells were removed. 
One hour later, the cell suspension was adjusted for cell 
density and inoculated equally in a 6-well plate and 
placed in a CO2 incubator and they were incubated at 
37℃ in a humidified atmosphere of 95% air and 5% CO2 
with the medium replaced every 24 h. In the first 48 h, 
5-bromodeoxyuridine (0.1 mM) was added to prevent the 
proliferation of non-myocardial cells. Eventually more 
than 95% of the cells were myocardial cells as evidenced 
by identification using an immunohistochemical method 
with an α-sarcomeric actin antibody. 
RNA Intervention 
When the cells were grown to almost 80% fusion, siRNA 
intervention was conducted. The attached cells were 
diluted with normal medium to 1×105 cells/well. Then 
2–8 µl of siRNA transfection reagents A and B were 
diluted separately to 100 µl with siRNA transfection 
medium containing no serum or antibiotics, and then 
were mixed gently, and incubated for 15–45 min at room 
temperature. The cells were washed once with 2 ml of 
siRNA transfection medium. For each transfection, 0.8 
ml siRNA transfection medium was put into each tube 
containing the siRNA transfection reagent mixture 
(solution A + solution B), mixed gently, added to the 
Journal of Traditional Chinese Medicine, December 2010; 30(4): 259-264 
 
261
culture plate, and incubated for 5–7 h at 37℃ in a CO2 
incubator. Then 1 ml of normal growth medium 
containing the normal serum was added. The cells were 
cultured for an additional 18–24 h and the medium was 
replaced with fresh normal growth medium. After 24–72 
h of culture, PHB expression was assayed with western 
blotting to assess the silencing of PHB siRNA. 
Myocardial Apoptosis  
The cell apoptosis was analyzed by flow cytometry after 
staining DNA with propidium iodide (PI) and Annexin 
V-FITC. After treatment with 5 µg/ml of Tan IIA, cells 
were trypsinized, washed with ice-cold PBS, and fixed 
with 70% ethanol overnight at −20℃. Then the cells 
were washed with ice-cold PBS and treated with 200 µl 
of RNase A (1 mg/ml) at 37℃ for 30–60 min. The cells 
were then incubated with 800 µl of PI staining buffer (0.1 
mg/ml PI and 1% Triton X-100 in PBS) at 4℃ in the 
dark for 30 min. The cells were analyzed on a 
FACSCalibur Flow Cytometer (Becton Dickinson, 
Franklin Lakes, NJ).  
Measurement of Mitochondrial Membrane Potential 
Myocardial cells were trypsinized with 0.125% trypsin 
and diluted to a concentration of 1×105 cells/ml. After 
washing twice with PBS, they were suspended with 
Rh123 (100 µ g/L) which was prepared using 1 g/L 
Rh123 in DMSO at -20℃ diluted with DMEM without 
calf serum, and incubated at 37℃, 5% CO2 for 45 
minutes in darkness. Mitochondrial membrane potential 
was analyzed by flow cytometry (λem= 488nm, λex= 525 
nm), and the measured data were processed using 
CellQuest software. Mitochondrial membrane potential 
was expressed by the mean fluorescence intensity of the 
positive cells. 
Measurement of Intracellular Calcium Concentration 
Adherent myocardial cells were trypsinized with 0.125% 
trypsin and diluted to a concentration of 1×106 cells/ml, 
and washed twice with PBS. They were loaded with 
Fluo-3/AM at a final concentration of 10 µ mol/L and 
incubated at 37℃, 5% CO2 for 30 min in the dark at 
room temperature. After the cells were attached and 
washed 2–3 times with PBS, Ca2+ responses were 
detected using a flow cytometer (Becton Dickinson) 
within 60 minutes (λem= 527 nm, λex= 506 nm). The 
intracellular calcium concentration was calculated by the 
formula: [Ca2+]i=Kd [(F-Fmin)/(Fmax-F)]. Kd is the 
dissociation constant of Fluo-3, i.e., 400 nM; F is the 
channel fluorescence intensities of each sample; Fmax 
and Fmin represents the channel fluorescence intensity of 
each sample added to 0.1% Triton X-100 and 5 mM 
EGTA, respectively. 
Western Blotting 
Protein concentration was determined by BCA assay and 
after SDS–PAGE electrophoresis, the protein was 
transferred to a PVDF membrane. After mounting with 
TBST (Tris-buffered saline + 0.1% Tween-20) containing 
non-fat dry milk (5% w/v) for 2 h, the membrane was 
incubated with 1:800 PHB primary monoclonal antibody 
overnight at 4℃. After washing with TBST 3 times, the 
membrane was incubated with HRP-conjugated goat 
anti-mouse secondary antibody (1:1000) for 1 h at room 
temperature. After washing 3 times with TBST, the blots 
were developed using a chemiluminescence detection kit. 
The image was scanned using a gel image analysis 
system, and the grey scale values of the experimental 
points were compared with that of the internal reference 
β -actin, and statistically analyzed with Kodak Software. 
Data Analysis 
The data were expressed as x ±s and analyzed with 
SPSS13.0 statistical software. One-way ANOVA was 
used for comparison among many groups of data and the 
LSD test was used for comparison between two groups. 
P<0.05 was considered as statistically significant.  
RESULTS 
Effects of Tanshinone IIA and siRNA on Apoptotic 
Rate, [Ca2+]i and MMP of Myocardial Cells 
In the oxidative stress group, the apoptotic rate and 
[Ca2+]i in the myocardial cells were significantly 
increased and MMP was significantly decreased as 
compared with the normal control group (all P<0.05). In 
the TSN group and the siRNA group, the apoptotic rate, 
and [Ca2+]i significantly increased and MMP in 
myocardial cells was decreased compared with the model 
group (all P<0.05). In the siRNA + oxidative stress group, 
the apoptotic rate and [Ca2+]i significantly increased and 
MMP decreased in myocardial cells as compared with 
the oxidative stress group as shown in Table 1.
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Table 1. Effect of tanshinone IIA (TSN) and siRNA on apoptotic rate, [Ca2+]i and MMP of myocardial cells 
Group Apoptotic rate (%) [Ca2+]i (nmol/L) MMP 
Normal control 2.53±0.18  94.56±4.51 83.65±1.79 
Oxidative stress 44.82±2.43*  277.27±7.81* 47.54±1.34* 
TSN  17.48±1.20*▲   133.35±8.64*▲ 76.53±1.21*▲ 
siRNA  13.56±1.03*▲    133.59±10.90*▲ 79.32±0.81*▲ 
siRNA+oxidative stress  58.27±1.23*▲   336.65±7.85*▲ 40.99±2.18*▲ 
siRNA negative control  2.66±0.13▲   92.22±5.25▲ 83.70±0.98▲ 
Notes: Compared with the normal control group , *P<0.05; Compared with the oxidative stress group, ▲P<0.05. 
Effects of Tanshinone IIA and siRNA on PHB Protein 
Experiment in Myocardial Cells 
The ratio of the grey scale value of PHB to that of 
β -actin in the normal control group was set as 1, and the 
ratio was 1.691±0.041 in the oxidative stress group, 
1.261±0.058 in the TSN group, 0.553±0.020 in the 
siRNA group, 0.576±0.019 in the siRNA+oxidative 
stress group, and 0.992±0.033 in the siRNA negative 
control group. Statistical analysis indicated that the 
expression of PHB in myocardial cells in an oxidative 
stress state increased significantly, which was attenuated 
by TSN pretreatment. Application of siRNA against 
prohibitin significantly decreased PHB expression, 
indicating an obvious gene silencing effect. The 
expression of PHB was not affected in the siRNA 
negative control group as shown in Figure 1. 
 
Figure 1. Effects of tanshinone IIA and siRNA on PHB 
protein expression in myocardial cells. 1. The normal 
control group; 2. The oxidative stress group; 3. The TSN 
group; 4. The siRNA group; 5. The siRNA + oxidative 
stress group; 6. The siRNA negative control group. 
DISCUSSION 
Coronary artery bypass grafting (CABG), thrombolytic 
therapy, coronary intervening therapy and extracorporeal 
circulation all can induce ischemia-reperfusion injury 
(I/RI). At present, the mechanism of I/RI is not 
completely clear, but many experimental studies have 
shown that a large number of oxygen free radicals (active 
oxygen) produced in reperfusion lead to structure injury, 
dysfunction and metabolic disturbance of cells, and I/IR 
not only results in cell necrosis, but also induces cell 
apoptosis. 5-8 Excessive apoptosis can lead to a decrease 
of cell number, structure destruction and dysfunction of 
myocardial cells. It is possible that intracellular calcium 
ion may initiate apoptosis, and inhibition of calcium 
concentration may prevent the induced apoptosis.9,10 
Decrease of MMP occurs in the early period of apoptosis, 
indicating that the mitochondrial membrane structure has 
been damaged. In this study, it was determined that 
exogenous H2O2 at a concentration of 200 µ mol/L could 
induce a significant increase in apoptosis rate and [Ca2+]i, 
and a significant decrease of MMP. However, after TSN 
was added, the apoptosis rate and [Ca2+]i were 
significantly decreased, and the MMP was significantly 
increased, indicating that TSN has a protective effect on 
myocardial cell apoptosis induced by oxidative stress. 
PHB gene was first found as a tumor suppressor gene, 
and it is also called anti-proliferin because of its 
significant anti-proliferation and anti-tumor effects.11 
Prohibitin protein is localized in the inner mitochondrial 
membrane functioning as a molecular chaperone, and in 
the nuclear membrane functioning in transcriptional 
control.12-14 Natural substrates of PHB include many 
kinds of proteins, such as cytochrome oxidase and 
compound I in the mitochondrial oxidation-reduction 
respiratory chain, among others. Upon disturbance of 
mitochondrial protein synthesis, PHB increases and plays 
a role as a molecular chaperone to stabilize various 
metabolic functions.15 PHB in mitochondria can regulate 
ion channels and production of calcium-dependent ATP, 
suggesting that PBH is possibly related to intercellular 
energy metabolism.16 The relationship between PHB 
protein and diseases has been studied using 
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proteomics.17-20 The authors’ previous study confirmed 
that in ischemia/reperfusion, PHB protein expression was 
increased in rats, which is in accordance with Kim’s 
study result.4,21 In the present study, it was shown that 
prohibitin protein helped to resist the myocardial 
apoptosis induced by H2O2. 
RNA interference (RNAi) technique also known as 
mRNA post-transcription gene silencing (PTGS) works 
by specific inhibition of specially designated target genes 
by complementary exogenous small interfering RNA 
(siRNA).22 In the present study, after interference of 
specific siRNA of PHB, PHB expression was not 
completely inhibited, but the PHB band in the siRNA 
group had become significantly more thin and light as 
compared with the normal group, indicating that the PHB 
expression level was decreased. After the inhibition of 
prohibitin expression by siRNA, the cell apoptosis rate 
and [Ca2+]i significantly increased, and mitochondrial 
membrane potential significantly decreased as compared 
with the normal group. The cell apoptosis rate and 
[Ca2+]i significantly increased and MMP decreased in the 
siRNA + oxidative stress group as compared with the 
oxidative stress group. These results indicated that PHB 
protein has a protective effect on myocardial cells under 
oxidative stress similar to another report that PHB has 
anti-oxidation activities. 23 
TSN, the main component of Danshen (丹参 Radix 
Salvia miltiorrhiza), is a natural antioxidative reagent 
and it can effectively inhibit cellular lipid peroxidation.24 
In the present study, the outstanding protective action of 
TSN on myocardial cells under a state of oxidative stress 
and the decrease in the level of expression of PHB 
protein seem to be contradictory. However, the results 
indicated that the increase of prohibitin protein 
expression in myocardial ischemia injury may be a 
compensatory response to oxidative stress.4 A current 
study shows that interleukin-6 (IL-6) can stimulate PHB 
protein expression in enteric epithelium and the 
regulative effect of IL-6 is controlled by signal 
transducer and activator of transcription 3 (STAT3).23 
Many studies show that a lot of inflammatory factors 
participate in the process of ischemia-reperfusion injury, 
and TSN has anti-inflammatory action and can 
effectively down-regulate expression of these infla- 
mmatory factors, such as IL-6, TNF-α  and so on.25-28 In 
this study, it was determined that the PHB protein level 
in myocardial cells was down-regulated by TSN 
pretreatment under conditions of oxidative stress, but it 
was still higher than that in the normal control group. 
There may be two reasons for this. First, TSN may have 
down-regulated PHB by attenuating the oxidative injury 
of myocardial cells leading to a decrease of prohibitin 
protein expression. Second, TSN may promote direct 
expression of PHB protein during oxidative injury. The 
study of the mechanism of TSN in regulating PHB 
expression is ongoing. 
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